Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 24301-24302 [2013-09690]
Download as PDF
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
obtaining an exemption from the vision
requirements (71 FR 32183; 71 FR
41310; 72 FR 12666; 72 FR 25831; 73 FR
61925; 74 FR 11988; 74 FR 15586; 74 FR
21427; 75 FR 54958; 75 FR 70078; 76 FR
9856 76 FR 17481; 76 FR 17483; 76 FR
20076; 76 FR 21796; 76 FR 28125). Each
of these 15 applicants has requested
renewal of the exemption and has
submitted evidence showing that the
vision in the better eye continues to
meet the requirement specified at 49
CFR 391.41(b)(10) and that the vision
impairment is stable. In addition, a
review of each record of safety while
driving with the respective vision
deficiencies over the past two years
indicates each applicant continues to
meet the vision exemption
requirements. These factors provide an
adequate basis for predicting each
driver’s ability to continue to drive
safely in interstate commerce.
Therefore, FMCSA concludes that
extending the exemption for each
renewal applicant for a period of two
years is likely to achieve a level of safety
equal to that existing without the
exemption.
Request for Comments
FMCSA will review comments
received at any time concerning a
particular driver’s safety record and
determine if the continuation of the
exemption is consistent with the
requirements at 49 U.S.C. 31136(e) and
31315. However, FMCSA requests that
interested parties with specific data
concerning the safety records of these
drivers submit comments by May 24,
2013.
FMCSA believes that the
requirements for a renewal of an
exemption under 49 U.S.C. 31136(e) and
31315 can be satisfied by initially
granting the renewal and then
requesting and evaluating, if needed,
subsequent comments submitted by
interested parties. As indicated above,
the Agency previously published
notices of final disposition announcing
its decision to exempt these 15
individuals from the vision requirement
in 49 CFR 391.41(b)(10). The final
decision to grant an exemption to each
of these individuals was made on the
merits of each case and made only after
careful consideration of the comments
received to its notices of applications.
The notices of applications stated in
detail the qualifications, experience,
and medical condition of each applicant
for an exemption from the vision
requirements. That information is
available by consulting the above cited
Federal Register publications.
Interested parties or organizations
possessing information that would
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
otherwise show that any, or all, of these
drivers are not currently achieving the
statutory level of safety should
immediately notify FMCSA. The
Agency will evaluate any adverse
evidence submitted and, if safety is
being compromised or if continuation of
the exemption would not be consistent
with the goals and objectives of 49
U.S.C. 31136(e) and 31315, FMCSA will
take immediate steps to revoke the
exemption of a driver.
Issued on: April 12, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013–09697 Filed 4–23–13; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2013–0106]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of applications for
exemption, request for comments.
AGENCY:
FMCSA announces receipt of
applications from 10 individuals for an
exemption from the prohibition against
persons with a clinical diagnosis of
epilepsy or any other condition which
is likely to cause a loss of consciousness
or any loss of ability to operate a
commercial motor vehicle (CMV) from
operating CMVs in interstate commerce.
The regulation and the associated
advisory criteria published in the Code
of Federal Regulations as the
‘‘Instructions for Performing and
Recording Physical Examinations’’ have
resulted in numerous drivers being
prohibited from operating CMVs in
interstate commerce based on the fact
that they have had one or more seizures
and are taking anti-seizure medication,
rather than an individual analysis of
their circumstances by a qualified
medical examiner. If granted, the
exemptions would enable these
individuals who have had one or more
seizures and are taking anti-seizure
medication to operate CMVs for 2 years
in interstate commerce.
DATES: Comments must be received on
or before May 24, 2013.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket ID FMCSA–
2013–0106– using any of the following
methods:
SUMMARY:
PO 00000
Frm 00152
Fmt 4703
Sfmt 4703
24301
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal
Holidays.
• Fax: 1–202–493–2251.
Each submission must include the
Agency name and the docket ID for this
Notice. Note that DOT posts all
comments received without change to
https://www.regulations.gov, including
any personal information included in a
comment. Please see the Privacy Act
heading below.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue SE., Washington, DC, between 9
a.m. and 5 p.m., Monday through
Friday, except Federal holidays. The
FDMS is available 24 hours each day,
365 days each year. If you want
acknowledgment that we received your
comments, please include a selfaddressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of our dockets by the
name of the individual submitting the
comment (or of the person signing the
comment, if submitted on behalf of an
association, business, labor union, etc.).
You may review the DOT’s complete
Privacy Act Statement in the Federal
Register published on January 17, 2008
(73 FR 3316; January 17, 2008). This
information is also available at https://
Docketinfo.dot.gov.
FOR FURTHER INFORMATION CONTACT:
Elaine Papp, Chief, Medical Programs
Division, (202) 366–4001, or via email at
fmcsamedical@dot.gov, or by letter
FMCSA, Room W64–113, Department of
Transportation, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31315 and 31136(e),
FMCSA may grant an exemption for a 2-
E:\FR\FM\24APN1.SGM
24APN1
tkelley on DSK3SPTVN1PROD with NOTICES
24302
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
year period if it finds ‘‘such exemption
would likely achieve a level of safety
that is equivalent to or greater than the
level that would be achieved absent
such exemption.’’ The statutes also
allow the Agency to renew exemptions
at the end of the 2-year period. The 10
individuals listed in this notice have
recently requested an exemption from
the epilepsy prohibition in 49 CFR
391.41(b)(8), which applies to drivers
who operate CMVs as defined in 49 CFR
390.5, in interstate commerce. Section
391.41(b)(8) states that a person is
physically qualified to drive a
commercial motor vehicle if that person
has no established medical history or
clinical diagnosis of epilepsy or any
other condition which is likely to cause
the loss of consciousness or any loss of
ability to control a CMV.
FMCSA provides medical advisory
criteria for use by medical examiners in
determining whether drivers with
certain medical conditions should be
certified to operate CMVs in intrastate
commerce. The advisory criteria
indicate that if an individual has had a
sudden episode of a non-epileptic
seizure or loss of consciousness of
unknown cause which did not require
anti-seizure medication, the decision
whether that person’s condition is likely
to cause the loss of consciousness or
loss of ability to control a CMV should
be made on an individual basis by the
medical examiner in consultation with
the treating physician. Before
certification is considered, it is
suggested that a 6-month waiting period
elapse from the time of the episode.
Following the waiting period, it is
suggested that the individual have a
complete neurological examination. If
the results of the examination are
negative and anti-seizure medication is
not required, then the driver may be
qualified.
In those individual cases where a
driver had a seizure or an episode of
loss of consciousness that resulted from
a known medical condition (e.g., drug
reaction, high temperature, acute
infectious disease, dehydration, or acute
metabolic disturbance), certification
should be deferred until the driver has
fully recovered from that condition, has
no existing residual complications, and
is not taking anti-seizure medication.
Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and
seizure-free for 10 years, may be
qualified to operate a CMV in interstate
commerce. Interstate drivers with a
history of a single unprovoked seizure
may be qualified to drive a CMV in
interstate commerce if seizure-free and
off anti-seizure medication for a 5-year
period or more.
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
Summary of Applications
Steven L. Gordon
Mr. Gordon is a 57 year-old CMV
driver in Montana. He has a history of
seizures as a result of a head injury in
1986 and his last seizure was in 2005.
He takes anti-seizure medication with
the dosage and frequency remaining the
same for over 7 years. If granted the
exemption, he would like to drive a
tractor trailer. His physician states he is
supportive of Mr. Gordon receiving an
exemption to operate a CMV.
Kevin A. Jandreau
Mr. Jandreau is a 46 year-old Class A
CMV driver in Maine. He has a
diagnosis of seizure disorder. He has
remained seizure free for at least 15
years. He takes anti-seizure medication
with the dosage and frequency
remaining the same for 15 years. If
granted the exemption, he would like to
drive a tractor trailer.
Jason C. Kirkham
Mr. Kirkham is a 39 year-old CMV
driver in Wisconsin. He has a history of
seizures and has remained seizure free
for 17 years. He takes anti-seizure
medication with the dosage and
frequency remaining the same for 17
years. If granted the exemption, he
would like to drive straight trucks,
cranes, or heavy equipment. His
physician states he is supportive of Mr.
Kirkham receiving an exemption.
James M. Kivett, Jr.
Mr. Kivett is a 49 year-old CMV driver
in Ohio. He has a history of seizures due
to a brain tumor, which was removed in
2005. He has remained seizure free for
more than 1 year. He takes anti-seizure
medication. If granted the exemption, he
would like to drive a tractor trailer. His
physician states he is supportive of Mr.
Kivett returning to work as a
commercial driver after 3 months.
William P. Lago
Mr. Lago is a 26 year-old driver in
Massachusetts. He has a diagnosis of
epilepsy and has remained seizure free
for 8 years. He takes anti-seizure
medication with the dosage and
frequency remaining the same since
June 2010. If granted the exemption, he
would like to drive a dump truck.
Michael K. Lail
Mr. Lail is a 54 year-old CMV driver
in North Carolina. He had a single posttraumatic seizure 46 years ago and has
remained seizure free since that time.
Mr. Lail has not taken anti-seizure
medication since July 2012. If granted
the exemption, he would like to drive a
PO 00000
Frm 00153
Fmt 4703
Sfmt 9990
tractor trailer. His physician states he is
supportive of Mr. Lail receiving an
exemption.
Verbon T. Latta
Mr. Latta is a 43 year-old driver in
Alabama. He has had 2 seizures, both in
May of 2007, 13 days apart while on a
new medication following back surgery.
He has remained seizure free since that
time. He takes anti-seizure medication
with the dosage and frequency
remaining the same for 6 years. If
granted the exemption, he would like to
drive a tractor trailer.
Jeffrey P. Moore
Mr. Moore is a 36 year-old driver in
New York. He has a diagnosis of seizure
disorder and his last seizure was in July
of 1999. He has remained seizure free
since that time. He takes anti-seizure
medication with the dosage and
frequency remaining the same for over
12 years. If granted the exemption, he
would like to drive a box truck or van.
Michael E. Righter
Mr. Righter is a 38 year-old driver in
Pennsylvania. Mr. Righter has a
diagnosis of seizure disorder and his
last seizure was in March of 1987. He
has remained seizure free since that
time. He takes anti-seizure medication
with the dosage and frequency
remaining the same for over 20 years. If
granted the exemption, he would like to
drive a Class B truck with air brakes.
Douglas S. Slagel
Mr. Slagel is a 48 year-old CMV driver
in Ohio. Mr. Slagel has a diagnosis of
seizure disorder and his last seizure was
in 1977. He has remained seizure free
since that time. He takes anti-seizure
medication with the dosage and
frequency remaining the same for over
20 years. If granted the exemption, he
would like to a Class B truck with air
brakes. His physician is supportive of
Mr. Slagel receiving his exemption.
Request for Comments
In accordance with 49 U.S.C. 31315
and 31136(e), FMCSA requests public
comment from all interested persons on
the exemption applications described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
earlier in the notice.
Issued on: April 9, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013–09690 Filed 4–23–13; 8:45 am]
BILLING CODE 4910–EX–P
E:\FR\FM\24APN1.SGM
24APN1
Agencies
[Federal Register Volume 78, Number 79 (Wednesday, April 24, 2013)]
[Notices]
[Pages 24301-24302]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09690]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2013-0106]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of applications for exemption, request for comments.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 10 individuals
for an exemption from the prohibition against persons with a clinical
diagnosis of epilepsy or any other condition which is likely to cause a
loss of consciousness or any loss of ability to operate a commercial
motor vehicle (CMV) from operating CMVs in interstate commerce. The
regulation and the associated advisory criteria published in the Code
of Federal Regulations as the ``Instructions for Performing and
Recording Physical Examinations'' have resulted in numerous drivers
being prohibited from operating CMVs in interstate commerce based on
the fact that they have had one or more seizures and are taking anti-
seizure medication, rather than an individual analysis of their
circumstances by a qualified medical examiner. If granted, the
exemptions would enable these individuals who have had one or more
seizures and are taking anti-seizure medication to operate CMVs for 2
years in interstate commerce.
DATES: Comments must be received on or before May 24, 2013.
ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket ID FMCSA-2013-0106- using any of the
following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov. Follow the on-line instructions for submitting
comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal Holidays.
Fax: 1-202-493-2251.
Each submission must include the Agency name and the docket ID for
this Notice. Note that DOT posts all comments received without change
to https://www.regulations.gov, including any personal information
included in a comment. Please see the Privacy Act heading below.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments on-line.
Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the DOT's complete Privacy Act Statement in the Federal
Register published on January 17, 2008 (73 FR 3316; January 17, 2008).
This information is also available at https://Docketinfo.dot.gov.
FOR FURTHER INFORMATION CONTACT: Elaine Papp, Chief, Medical Programs
Division, (202) 366-4001, or via email at fmcsamedical@dot.gov, or by
letter FMCSA, Room W64-113, Department of Transportation, 1200 New
Jersey Avenue SE., Washington, DC 20590-0001. Office hours are from
8:30 a.m. to 5 p.m., Monday through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31315 and 31136(e), FMCSA may grant an exemption
for a 2-
[[Page 24302]]
year period if it finds ``such exemption would likely achieve a level
of safety that is equivalent to or greater than the level that would be
achieved absent such exemption.'' The statutes also allow the Agency to
renew exemptions at the end of the 2-year period. The 10 individuals
listed in this notice have recently requested an exemption from the
epilepsy prohibition in 49 CFR 391.41(b)(8), which applies to drivers
who operate CMVs as defined in 49 CFR 390.5, in interstate commerce.
Section 391.41(b)(8) states that a person is physically qualified to
drive a commercial motor vehicle if that person has no established
medical history or clinical diagnosis of epilepsy or any other
condition which is likely to cause the loss of consciousness or any
loss of ability to control a CMV.
FMCSA provides medical advisory criteria for use by medical
examiners in determining whether drivers with certain medical
conditions should be certified to operate CMVs in intrastate commerce.
The advisory criteria indicate that if an individual has had a sudden
episode of a non-epileptic seizure or loss of consciousness of unknown
cause which did not require anti-seizure medication, the decision
whether that person's condition is likely to cause the loss of
consciousness or loss of ability to control a CMV should be made on an
individual basis by the medical examiner in consultation with the
treating physician. Before certification is considered, it is suggested
that a 6-month waiting period elapse from the time of the episode.
Following the waiting period, it is suggested that the individual have
a complete neurological examination. If the results of the examination
are negative and anti-seizure medication is not required, then the
driver may be qualified.
In those individual cases where a driver had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has fully recovered from that
condition, has no existing residual complications, and is not taking
anti-seizure medication. Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and seizure-free for 10 years,
may be qualified to operate a CMV in interstate commerce. Interstate
drivers with a history of a single unprovoked seizure may be qualified
to drive a CMV in interstate commerce if seizure-free and off anti-
seizure medication for a 5-year period or more.
Summary of Applications
Steven L. Gordon
Mr. Gordon is a 57 year-old CMV driver in Montana. He has a history
of seizures as a result of a head injury in 1986 and his last seizure
was in 2005. He takes anti-seizure medication with the dosage and
frequency remaining the same for over 7 years. If granted the
exemption, he would like to drive a tractor trailer. His physician
states he is supportive of Mr. Gordon receiving an exemption to operate
a CMV.
Kevin A. Jandreau
Mr. Jandreau is a 46 year-old Class A CMV driver in Maine. He has a
diagnosis of seizure disorder. He has remained seizure free for at
least 15 years. He takes anti-seizure medication with the dosage and
frequency remaining the same for 15 years. If granted the exemption, he
would like to drive a tractor trailer.
Jason C. Kirkham
Mr. Kirkham is a 39 year-old CMV driver in Wisconsin. He has a
history of seizures and has remained seizure free for 17 years. He
takes anti-seizure medication with the dosage and frequency remaining
the same for 17 years. If granted the exemption, he would like to drive
straight trucks, cranes, or heavy equipment. His physician states he is
supportive of Mr. Kirkham receiving an exemption.
James M. Kivett, Jr.
Mr. Kivett is a 49 year-old CMV driver in Ohio. He has a history of
seizures due to a brain tumor, which was removed in 2005. He has
remained seizure free for more than 1 year. He takes anti-seizure
medication. If granted the exemption, he would like to drive a tractor
trailer. His physician states he is supportive of Mr. Kivett returning
to work as a commercial driver after 3 months.
William P. Lago
Mr. Lago is a 26 year-old driver in Massachusetts. He has a
diagnosis of epilepsy and has remained seizure free for 8 years. He
takes anti-seizure medication with the dosage and frequency remaining
the same since June 2010. If granted the exemption, he would like to
drive a dump truck.
Michael K. Lail
Mr. Lail is a 54 year-old CMV driver in North Carolina. He had a
single post-traumatic seizure 46 years ago and has remained seizure
free since that time. Mr. Lail has not taken anti-seizure medication
since July 2012. If granted the exemption, he would like to drive a
tractor trailer. His physician states he is supportive of Mr. Lail
receiving an exemption.
Verbon T. Latta
Mr. Latta is a 43 year-old driver in Alabama. He has had 2
seizures, both in May of 2007, 13 days apart while on a new medication
following back surgery. He has remained seizure free since that time.
He takes anti-seizure medication with the dosage and frequency
remaining the same for 6 years. If granted the exemption, he would like
to drive a tractor trailer.
Jeffrey P. Moore
Mr. Moore is a 36 year-old driver in New York. He has a diagnosis
of seizure disorder and his last seizure was in July of 1999. He has
remained seizure free since that time. He takes anti-seizure medication
with the dosage and frequency remaining the same for over 12 years. If
granted the exemption, he would like to drive a box truck or van.
Michael E. Righter
Mr. Righter is a 38 year-old driver in Pennsylvania. Mr. Righter
has a diagnosis of seizure disorder and his last seizure was in March
of 1987. He has remained seizure free since that time. He takes anti-
seizure medication with the dosage and frequency remaining the same for
over 20 years. If granted the exemption, he would like to drive a Class
B truck with air brakes.
Douglas S. Slagel
Mr. Slagel is a 48 year-old CMV driver in Ohio. Mr. Slagel has a
diagnosis of seizure disorder and his last seizure was in 1977. He has
remained seizure free since that time. He takes anti-seizure medication
with the dosage and frequency remaining the same for over 20 years. If
granted the exemption, he would like to a Class B truck with air
brakes. His physician is supportive of Mr. Slagel receiving his
exemption.
Request for Comments
In accordance with 49 U.S.C. 31315 and 31136(e), FMCSA requests
public comment from all interested persons on the exemption
applications described in this notice. We will consider all comments
received before the close of business on the closing date indicated
earlier in the notice.
Issued on: April 9, 2013.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2013-09690 Filed 4-23-13; 8:45 am]
BILLING CODE 4910-EX-P